Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma

Annals of Nuclear Medicine

Volumn 23, Issue 2, 2009, Pages 155-161

  Tateishi, Ukihide ^a   Hosono, Ako ^b   Makimoto, Atsushi ^b   Nakamoto, Yuki ^c   Kaneta, Tomohiro ^d   Fukuda, Hiroshi ^d   Murakami, Koji ^e   Terauchi, Takashi ^f   Suga, Tsuyoshi ^c   Inoue, Tomio ^a   Kim, Edmund E ^g  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e DOKKYO MEDICAL UNIVERSITY   (Japan)

^f NATIONAL CANCER CENTER   (Japan)

^g UNIVERSITY OF TEXAS   (United States)

Author keywords

FDG PET CT; Rhabdomyosarcoma; Stage

Indexed keywords

FLUORODEOXYGLUCOSE F 18; OXIDRONATE TECHNETIUM TC 99M; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ADULT; ARTICLE; BONE SCINTISCANNING; CANCER STAGING; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHABDOMYOSARCOMA; THORAX RADIOGRAPHY; EVALUATION; METHODOLOGY; PATHOLOGY; PRESCHOOL CHILD; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SOFT TISSUE TUMOR;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RHABDOMYOSARCOMA; SENSITIVITY AND SPECIFICITY; SOFT TISSUE NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 65349140644     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12149-008-0219-z     Document Type: Article

References (15)

1. A. Hates-Jordan D.K. Doherty S.D. West R.B. Raney M.L. Blakely C.S. Cox Jr 2006 Outcome after surgical resection of recurrent rhabdomyosarcoma J Pediatr 41 633 638
2. M.B. McCarville R. Christie N.C. Daw S.L. Spunt S.C. Kaste 2005 PET/CT in the evaluation of childhood sarcomas Am J Roentogenol 184 1293 304
3. O.E. Nieweg J. Pruim R.J. van Ginkel H.J. Hoekstra A.M. Paans W.M. Molenaar 1996 Fluorine-18-fluorodeoxyglucose PET imaging of soft-tissue sarcoma J Nucl Med 37 257 261 (Pubitemid 26150898)
4. J.F. Eary E.U. Conrad J.D. Bruckner A. Folpe K.J. Hunt D.A. Mankoff 1998 Quantitative [F-18]fluorodeoxyglucose positron emission tomography in pretreatment and grading of sarcoma Clin Cancer Res 4 1215 1220 (Pubitemid 28213332)
5. C. Franzius J. Sciuk H.E. Daldrup-Link H. Jurgens O. Schober 2000 FDG-PET for detection of osseous metastases from malignant primary bone tumors: comparison with bone scintigraphy Eur J Nucl Med 27 1305 1311 (Pubitemid 30680618)
6. M.H.M. Schwarzbach A. Dimitrakopoulou-Strauss F. Willeke G. Mechtersheimer F. Willeke D. Bockler 2000 Clinical value of [18-F] fluorodeoxyglucose positron emission tomography imaging in soft tissue sarcomas Ann Surg 231 380 386 (Pubitemid 30137126)
7. M.L. Klem R.K. Grewal L.H. Wexler H. Schoder P.A. Meyers S.L. Wolden 2007 PET for staging in rhabdomyosarcoma: an evaluation of PET as an adjunct to current staging tools J Pediatr Hematol Oncol 29 9 14 (Pubitemid 46143019)
8. U. Tateishi U. Yamaguchi K. Seki T. Terauchi Y. Arai E.E. Kim 2006 Glut-1 expression and enhanced glucose metabolism are associated with tumor grade in bone and soft tissue sarcomas: a prospective evaluation by [F-18]- fluorodeoxyglucose positron emission tomography Eur J Nucl Med Mol Imaging 33 683 691 (Pubitemid 43846759)
9. R. Bar-Shalom N. Yefremov L. Guralnik D. Gaitini A. Frenkel A. Kuten 2003 Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management J Nucl Med 44 1200 1209 (Pubitemid 39655178)
10. C. Rodary F. Flamant S.S. Donaldson 1989 An attempt to use a common staging system in rhabdomyosarcoma: a report of an international workshop initiated by the International Society of Pediatric Oncology (SIOP) Med Pediatr Oncol 17 210 215 (Pubitemid 19187089)
11. M.W. Ben Arush R. Bar Shalom S. Postovsky D. Militianu M. Haimi I. Zaidman 2006 Assessing the use of FDG-PET in the detection of regional and metastatic nodes in alveolar rhabdomyosarcoma of extremities J Pediatr Hematol Oncol 28 440 445 (Pubitemid 44114552)
12. F. Peng G. Rabkin O. Muzik 2006 Use of 2-deoxy-2-[F-18]-fluoro-d-glucose positron emission tomography to monitor therapeutic response by rhabdomyosarcoma in children: report of a retrospective case study Clin Nucl Med 31 394 397 (Pubitemid 44315519)
13. R.J. Cohen R.E. Curtis P.D. Inskip J.F. Fraumeni Jr. 2005 The risk of developing second cancers among survivors of childhood soft tissue sarcoma Cancer 103 2391 2396 (Pubitemid 40686586)
14. D.C. Rich C.A. Corporon M.B. Smith C.T. Black K.P. Lally R.J. Andrassy 1997 Second malignant neoplasms in children after treatment of soft tissue sarcoma J Pediatr Surg 32 369 372 (Pubitemid 27082189)
15. U. Tateishi T. Hasegawa K. Miyakawa M. Sumi N. Moriyama 2003 CT and MRI features of recurrent tumors and second primary neoplasms in pediatric patients with rhabdomyosarcoma Am J Roentogenol 181 879 84